Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May-Jun;60(3):161-164.
doi: 10.4103/nmj.NMJ_93_18.

Towards 2030 Target for Hepatitis B and C Viruses Elimination: Assessing the Validity of Predonation Rapid Diagnostic Tests versus Enzyme-linked Immunosorbent Assay in State Hospitals in Kaduna, Nigeria

Ismaila Nda Ibrahim  1 , Aisha Indo Mamman  1 , Muhammad Shakir Balogun  2 , Aliyu Ahmadu Babadoko  1 , Abdulaziz Hassan  1 , Benjamin Augustine  1 , Aisha Maude Suleiman  1 , Ibrahim Usman Kusfa  1
Affiliations

Towards 2030 Target for Hepatitis B and C Viruses Elimination: Assessing the Validity of Predonation Rapid Diagnostic Tests versus Enzyme-linked Immunosorbent Assay in State Hospitals in Kaduna, Nigeria

Ismaila Nda Ibrahim et al. Niger Med J. 2019 May-Jun.

Abstract

Introduction: Sub-Saharan Africa accounts for 25% of the estimated global 325 million people with chronic hepatitis B and C virus infections. Weak blood transfusion systems facilitate the spread of both hepatitis B and C virus infections. This is worsened by the absence of sustainable quality assurance programs and perennial shortage of sensitive screening kits. We aim to compare the validity of rapid diagnostic tests (RDTs) with the World Health Organization-recommended quality-assured enzyme-linked immunosorbent assay (ELISA) screening method for these viruses.

Materials and methods: We conducted a cross-sectional study on consecutive blood donor samples. Two hundred and sixty-four blood donor samples screened for hepatitis B and C viruses using RDTs were retested at a National blood transfusion service, Kaduna, Nigeria. Data were analyzed using OpenEpi version 3.01 to determine the sensitivity, specificity, and predictive values of RDTs versus ELISA.

Results: The sensitivities of the RDTs at 95% confidence interval (CI) were low - 40% (19.8-64.3) and 50.0% (18.8-81.2) - for hepatitis B surface antigen (HBsAg) and hepatitis C virus (HCV) antibody, respectively. The specificities and 95% CI were high - 99.9% (97.8-99.9) and 100.0% (98.5-100) for HBsAg and HCV antibody, respectively.

Conclusion: Predonation RDTs screening of blood donor samples for hepatitis B virus and HCV in hospital donation units performed poorly compared to quality-assured ELISA screening in Kaduna. The risk of transmitting viral hepatitis through blood transfusion still exists. We recommend quality-assured ELISA screening of all donated units for HBsAg and HCV antibody to reduce the risk of these transfusion-transmitted infections.

Keywords: Blood donors; hepatitis B and C virus; rapid diagnostic tests; validity.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. World Health Organization. New Hepatitis Data Highlight Need for Urgent Global Response. WHO AFRO; 2017. [Last accessed 2019 Jul 02]. Available from: https://www.afro.who.int/news/new-hepatitis-data-highlight-need-urgent-g... .
    1. World Health Organization. Global Hepatitis Report 2017. WHO; 2017. [Last accessed 2019 Jul 02]. Available from: https://www.who.int/hepatitis/publications/globalhepatitis-report2017/en/
    1. Trucchi C, Orsi A, Alicino C, Sticchi L, Icardi G, Ansaldi F, et al. State of the art, unresolved issues, and future research directions in the fight against hepatitis C virus: Perspectives for screening, diagnostics of resistances, and immunization. J Immunol Res. 2016;2016:1412840. - PMC - PubMed
    1. Apata IW, Averhoff F, Pitman J, Bjork A, Yu J, Amin NA, et al. Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection – Sub-Saharan Africa, 2000-2011. MMWR Morb Mortal Wkly Rep. 2014;63:613–9. - PMC - PubMed
    1. Baha W, Foullous A, Dersi N, They-they TP, El alaoui K, Nourichafi N. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC Public Health. 2013;13:50. - PMC - PubMed